Literature DB >> 10085023

Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts.

X L Pang1, T Mitamura, T Horii.   

Abstract

The serine repeat antigen (SERA) is a vaccine candidate antigen of Plasmodium falciparum. Immunization of mice with Escherichia coli-produced recombinant protein of the SERA N-terminal domain (SE47') induced an antiserum that was inhibitory to parasite growth in vitro. Affinity-purified mouse antibodies specific to the recombinant protein inhibited parasite growth between the schizont and ring stages but not between the ring and schizont stages. When Percoll-purified schizonts were cultured with the affinity-purified SE47'-specific antibodies, schizonts and merozoites were agglutinated. Indirect-immunofluorescence assays with unfixed parasite cells showed that SE47'-specific immunoglobulin G (IgG) bound to SERA molecules on rupturing schizonts and merozoites but the IgG did not react with the schizont-infected erythrocytes (RBC). Furthermore, double-fluorescence staining against SE47'-specific IgG and anti-human RBC membrane IgG showed that the RBC membrane disappeared from SE47'-specific-IgG-bound schizonts after cultivation. These observations suggest that the SE47'-specific antibodies inhibit parasite growth by cross-linking SERA molecules that are associated with merozoites in rupturing schizonts with partly broken RBC and parasitophorous vacuole membranes, blocking merozoite release.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085023      PMCID: PMC96533          DOI: 10.1128/IAI.67.4.1821-1827.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Immunogenicity of recombinant Plasmodium falciparum SERA proteins in rodents.

Authors:  P J Barr; J Inselburg; K M Green; J Kansopon; B K Hahm; H L Gibson; C T Lee-Ng; D J Bzik; W B Li; I C Bathurst
Journal:  Mol Biochem Parasitol       Date:  1991-03       Impact factor: 1.759

2.  Localization, biosynthesis, processing and isolation of a major 126 kDa antigen of the parasitophorous vacuole of Plasmodium falciparum.

Authors:  P Delplace; B Fortier; G Tronchin; J F Dubremetz; A Vernes
Journal:  Mol Biochem Parasitol       Date:  1987-04       Impact factor: 1.759

3.  Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface by antibodies when schizonts mature in the presence of growth inhibitory immune serum.

Authors:  J A Lyon; J D Haynes; C L Diggs; J D Chulay; J M Pratt-Rossiter
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

4.  Protein p126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites.

Authors:  P Delplace; A Bhatia; M Cagnard; D Camus; G Colombet; A Debrabant; J F Dubremetz; N Dubreuil; G Prensier; B Fortier
Journal:  Biol Cell       Date:  1988       Impact factor: 4.458

5.  Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant.

Authors:  J Inselburg; I C Bathurst; J Kansopon; P J Barr; R Rossan
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Plasmodium yoelii and Plasmodium berghei: isolation of infected erythrocytes from blood by colloidal silica gradient centrifugation.

Authors:  C E Tosta; M Sedegah; D C Henderson; N Wedderburn
Journal:  Exp Parasitol       Date:  1980-08       Impact factor: 2.011

7.  Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes.

Authors:  J A Lyon; A W Thomas; T Hall; J D Chulay
Journal:  Mol Biochem Parasitol       Date:  1989-08       Impact factor: 1.759

8.  Malaria (Plasmodium knowlesi) merozoites: immunity and the surface coat.

Authors:  L H Miller; M Aikawa; J A Dvorak
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

9.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

10.  Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum.

Authors:  J Inselburg; D J Bzik; W B Li; K M Green; J Kansopon; B K Hahm; I C Bathurst; P J Barr; R N Rossan
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

View more
  23 in total

1.  Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.

Authors:  P V Lalitha; Lisa A Ware; Arnoldo Barbosa; Sheetij Dutta; J Kathleen Moch; J David Haynes; Bader B Fileta; Charles E White; David E Lanar
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

2.  Global identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease.

Authors:  Natalie C Silmon de Monerri; Helen R Flynn; Marta G Campos; Fiona Hackett; Konstantinos Koussis; Chrislaine Withers-Martinez; J Mark Skehel; Michael J Blackman
Journal:  Infect Immun       Date:  2011-01-10       Impact factor: 3.441

3.  Immunomic Identification of Malaria Antigens Associated With Protection in Mice.

Authors:  Anthony Siau; Ximei Huang; Han Ping Loh; Neng Zhang; Wei Meng; Siu Kwan Sze; Laurent Renia; Peter Preiser
Journal:  Mol Cell Proteomics       Date:  2019-02-04       Impact factor: 5.911

4.  Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum.

Authors:  A A Belperron; D Feltquate; B A Fox; T Horii; D J Bzik
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Specificity of the protective antibody response to apical membrane antigen 1.

Authors:  A N Hodder; P E Crewther; R F Anders
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models.

Authors:  Takahiro Tougan; Taiki Aoshi; Cevayir Coban; Yuko Katakai; Chieko Kai; Yasuhiro Yasutomi; Ken J Ishii; Toshihiro Horii
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

7.  Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.

Authors:  Xun-Jia Cheng; Hitoshi Hayasaka; Katsuomi Watanabe; Yan-Lin Tao; Jin-Ye Liu; Hideo Tsukamoto; Toshihiro Horii; Kazuyuki Tanabe; Hiroshi Tachibana
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

8.  Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design.

Authors:  Joanne E McCoubrie; Susanne K Miller; Tobias Sargeant; Robert T Good; Anthony N Hodder; Terence P Speed; Tania F de Koning-Ward; Brendan S Crabb
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

Review 9.  Malarial proteases and host cell egress: an 'emerging' cascade.

Authors:  Michael J Blackman
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

10.  The Plasmodium serine-type SERA proteases display distinct expression patterns and non-essential in vivo roles during life cycle progression of the malaria parasite.

Authors:  Elyzana D Putrianti; Anja Schmidt-Christensen; Iris Arnold; Volker T Heussler; Kai Matuschewski; Olivier Silvie
Journal:  Cell Microbiol       Date:  2009-12-21       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.